Saturday, July 30, 2016 4:40:51 PM
"Norchi has deep contacts in the world of contract manufacturing. Norchi said that Arch had spoken with many candidate contract manufacturers, and wanted one that could do scaled-up liquid phase peptide synthesis on both sides of the Atlantic equally. A contract is in place, and this organization is now making AC5 stocks. Norchi felt it would imprudent to name right now the manufacturer or the cost per unit for manufacture, but assured us that despite the relative expensiveness of making AC5, he is confident a price with considerable profit margin that the market will easily bear without drama or protest can be set. Arch has a consulting advisor who is the author of the leading textbook in biochemistry on methods of peptide synthesis."
Arch Therapeutics Science
http://sciencebehindac5.blogspot.com/
Elevator Summary of Arch http://www.archtherapeutics.blogspot.com/
Glidelogic Corp. Becomes TikTok Shop Partner, Opening a New Chapter in E-commerce Services • GDLG • Jul 5, 2024 7:09 AM
Freedom Holdings Corporate Update; Announces Management Has Signed Letter of Intent • FHLD • Jul 3, 2024 9:00 AM
EWRC's 21 Moves Gaming Studios Moves to SONY Pictures Studios and Green Lights Development of a Third Upcoming Game • EWRC • Jul 2, 2024 8:00 AM
BNCM and DELEX Healthcare Group Announce Strategic Merger to Drive Expansion and Growth • BNCM • Jul 2, 2024 7:19 AM
NUBURU Announces Upcoming TV Interview Featuring CEO Brian Knaley on Fox Business, Bloomberg TV, and Newsmax TV as Sponsored Programming • BURU • Jul 1, 2024 1:57 PM
Mass Megawatts Announces $220,500 Debt Cancellation Agreement to Improve Financing and Sales of a New Product to be Announced on July 11 • MMMW • Jun 28, 2024 7:30 AM